These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7117738)

  • 1. Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice.
    Ohkoshi M; Fujii S
    Gan; 1982 Feb; 73(1):108-10. PubMed ID: 7117738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate.
    Ohkoshi M
    Gan; 1981 Dec; 72(6):959-64. PubMed ID: 7341342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of mouse skin carcinoma in the rapid growing stage.
    Ohkoshi M; Fujii S
    J Dermatol; 1984 Feb; 11(1):21-4. PubMed ID: 6376571
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoyl-methyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin.
    Ohkoshi M; Fujii S
    J Natl Cancer Inst; 1983 Nov; 71(5):1053-7. PubMed ID: 6580482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate for prevention of recurrence of carcinoma of the mouth and in treatment of terminal carcinoma.
    Ohkoshi M; Oka T
    J Maxillofac Surg; 1984 Aug; 12(4):148-52. PubMed ID: 6590712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of mouse autochthonous skin cancer by oral administration of new serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2002; 22(2A):821-3. PubMed ID: 12014657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protease inhibitors as anticancer chemotherapy--experimental and clinical studies].
    Ohkoshi M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):417-30. PubMed ID: 7887633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serine protease inhibitor FOY-305 and heparin on the growth of squamous cell carcinoma.
    Ohkoshi M; Akagawa T; Nakajima M
    Anticancer Res; 1993; 13(4):963-6. PubMed ID: 8352567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal absorption of N,N'-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy) phenylacetate methanesulfonate in rats.
    Nishihata T; Saitoh Y; Sakai K
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2544-50. PubMed ID: 3240476
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of small intestinal absorption of N,N'-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy) phenylacetate methanesulfonate (FOY305) in rats.
    Nishihata T; Yoshitomi H; Ikawa C; Sakai K
    Chem Pharm Bull (Tokyo); 1988 Jul; 36(7):2703-7. PubMed ID: 3240495
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aprotinin on growth of 3-methylcholanthrene-induced squamous cell-carcinoma in mice.
    Ohkoshi M
    Gan; 1980 Apr; 71(2):246-50. PubMed ID: 6162702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-tumor effects of Picibanil on mouse skin squamous cell cancer (author's transl)].
    Kaneda T; Ichikawa H
    Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):787-96. PubMed ID: 387895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study relating to the anti-cancer effect of FT-207 suppository (author's transl)].
    Kaneda T; Ichikawa H; Hiraiwa K
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):1033-8. PubMed ID: 120401
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2001; 21(3B):1803-8. PubMed ID: 11497262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin B2 on tumorigenesis of 3-methylcholanthrene in the mouse skin.
    Ohkoshi M; Ohta H; Ito M
    Gan; 1982 Feb; 73(1):105-7. PubMed ID: 7117737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [20-methylcholanthrene-induced mice skin cancer. Part 1. Histological studies on tumor developing process (author's transl)].
    Hori M
    Nihon Hifuka Gakkai Zasshi; 1981 Jan; 91(1):25-31. PubMed ID: 6971354
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental study relating to the anti-cancer effect of doxifluridine].
    Zhao L; Kaneda T; Tohnai I; Shinoda T; Kasuya Y; Matsuyama M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1182-9. PubMed ID: 2144562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [20-methylcholanthrene induced mouse skin cancer. Part 4: Study on the similarity between mouse skin cancer and human non-cicatric squamous cell carcinoma (author's transl)].
    Hori M; Egami K; Hirose R; Toriyama F; Satomi G; Nakaura Y; Shinoda H
    Nihon Hifuka Gakkai Zasshi; 1981 May; 91(6):659-66. PubMed ID: 6975839
    [No Abstract]   [Full Text] [Related]  

  • 19. Histological studies on the development of skin neoplasms induced by methylcholanthrene in white mice.
    Kozakiewicz J; Szarmach H; Malinowska H
    Pol Med J; 1966; 5(6):1370-8. PubMed ID: 5973039
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic versus natural protease inhibitors in acute experimental pancreatitis.
    Lankisch PG; Pohl U; Otto J
    Dig Dis Sci; 1988 Nov; 33(11):1497-8. PubMed ID: 3180989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.